finance
CDC Delays Release of COVID-19 Vaccine Effectiveness Report
The Centers for Disease Control and Prevention has delayed the release of a report on COVID-19 vaccine effectiveness. The report, based on a study of over 1 million people, examines protection against emergency department and urgent care visits. A public health expert explained the reasons for the delay, including issues with the study methodology.
Apr 11, 12:32 PM·1m read1 source
dailywire.comAudio version
Tap play to generate a narrated version.
Delay A public health expert stated that the CDC identified issues in the study methodology that required further examination.
The expert noted that the review process aims to ensure the reliability of the findings before public release.
The 2023-2024 COVID-19 vaccines target variants circulating during the previous respiratory season.
The CDC routinely assesses vaccine performance through observational studies like VISION and IVY to inform public health recommendations.
This delay follows similar methodological reviews in prior vaccine effectiveness reports.
Public health officials emphasize the importance of timely data for vaccination campaigns.
The affected population includes all eligible individuals in the US, particularly those at higher risk such as older adults and people with underlying conditions.
The next steps involve completing the methodology review, after which the CDC plans to publish the updated report.
Stakeholders, including healthcare providers and policymakers, await the final results to guide booster recommendations and resource allocation.
The delay does not alter current vaccination guidelines, which continue to recommend the updated vaccines for most people aged 6 months and older.
